Table 2.
Antiviral activity of site 1 −1 PRF binders against SARS-CoV-2.
Analog | Structure | EC50 [μM] | CC50 [μM] |
---|---|---|---|
1 (AB-3234) |
![]() |
13.0 | >100 |
2 (AB-3241) |
![]() |
25.2 | >100 |
3 (AB-3285) |
![]() |
12.0 | >100 |
EC50 : half-maximal effective concentration, CC50: half-maximal cytotoxic concentration